Eric D. Shaff has sold MCRB and made no open-market buys since Mar 2016
Insider at Seres Therapeutics, Inc.
SEC CIK 0001643734 · Filings on SEC.gov ↗
$0Bought
$854KSold
NoneLast buy
Every filing
7 filings since Mar 2016, newest first
MCRBSell
Seres Therapeutics, Inc.
Insider
$25K−25.0%Jan 29
MCRBSell
Seres Therapeutics, Inc.
Insider
$31K−35.0%Jan 30
MCRBSell
Seres Therapeutics, Inc.
CFO and EVP
$134K−100.0%Jun 30
MCRBSell
Seres Therapeutics, Inc.
CFO and EVP
$141K−100.0%Jun 29
MCRBSell
Seres Therapeutics, Inc.
CFO and EVP
$189K−100.0%Apr 6
MCRBSell
Seres Therapeutics, Inc.
CFO and EVP
$202K−100.0%Apr 4
MCRBSell
Seres Therapeutics, Inc.
CFO and EVP
$132K−100.0%Mar 29
Filings come from SEC EDGAR. Not investment advice.